HIF‐1α‐Induced GPR171 Expression Mediates CCL2 Secretion by Mast Cells to Promote Gastric Inflammation During Helicobacter pylori Infection
Authors:
Open Access
- 4 May 2025
- journal article
- Published by Wiley in Helicobacter
- Vol. 30 (3) , e70042
Abstract
Background: Helicobacter pylori (H. pylori) infection is one of the most important risk factors for chronic gastritis, gastric ulcers, and gastric cancer. Mast cells act as a crucial regulator in bacterial infection. The mechanisms underlying mast cell activation and their role in H. pylori infection remain poorly understood.Materials and Methods: In gastric mucosal tissue, the number of mast cells, G‐protein‐coupled receptor 171 (GPR171) and CCL2 expression were detected by immunohistochemistry (IHC) or immunofluorescence between H. pylori‐negative and H. pylori‐positive patients. Mast cells were co‐cultured with H. pylori, and transcriptome sequencing, RT‐qPCR, and Western blotting (WB) were performed to identify receptors involved in mast cell activation. WB, chromatin immunoprecipitation (ChIP), and dual‐luciferase reporter assays were conducted to investigate the molecular mechanism by which HIF‐1α regulates GPR171 expression. Lentiviral knockdown, ELISA, WB, and IHC were used to evaluate the role of GPR171 during H. pylori infection. An in vivo mouse model of H. pylori infection was employed to assess the effects of GPR171 blockade on CCL2 expression and gastric mucosal inflammation.Results: In the study, we found that mast cell numbers were greatly increased and correlated with the severity of inflammation in H. pylori‐infected patients. We found a new receptor, GPR171, was upregulated and involved in mast cell activation upon H. pylori infection. Furthermore, H. pylori infection induced the expression of GPR171 by promoting the activation of hypoxia‐inducible factor 1 alpha (HIF‐1α), which directly bound to hypoxia response elements in the GPR171 promoter and regulated its transcriptional activity. Blockade or loss of GPR171 in mast cells partially inhibited CCL2 secretion via the ERK1/2 signaling pathway. In the human gastric mucosa, CCL2 derived from mast cells was associated with gastric inflammation during H. pylori infection. In vivo murine studies indicated that H. pylori infection significantly upregulated CCL2 expression, while GPR171 inhibition partially reduced CCL2 levels and alleviated gastric mucosal inflammation.Conclusions: We provide a novel mechanism that H. pylori activates mast cells to promote gastric inflammation.Keywords
Funding Information
- National Natural Science Foundation of China (81971489, 81671571)
This publication has 63 references indexed in Scilit:
- Toll‐like receptor 2 (TLR2) and TLR4 differentially activate human mast cellsEuropean Journal of Immunology, 2003
- Clearance ofHelicobacter pyloriInfection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized MiceInfection and Immunity, 2002
- Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunityJournal of Clinical Investigation, 2002
- Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori , Directly Activates Mast Cells for Migration and Production of Proinflammatory CytokinesThe Journal of Immunology, 2002
- The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cellsEuropean Journal of Immunology, 2002
- Stem Cell Factor Expressed in Human Gastric Mucosa in Relation to Mast Cell Increase in Helicobacter pylori-Infected GastritisDigestive Diseases and Sciences, 2002
- Effects of interleukin-8 and Helicobacter pylori on histamine release from isolated canine gastric mucosal mast cellsJournal of Gastroenterology, 2002
- Mast cell modulation of immune responses to bacteriaImmunological Reviews, 2001
- Mast cell involvement in gastritis with or without Helicobacter pylori infectionGastroenterology, 1997
- Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-αNature, 1996